Renato Opportunity

Ultimately, knowledge gained from prevention and early detection trials could have a vastly greater effect on reducing morbidity and mortality from cancer because the findings are applied to the entire at-risk population. Clinical trials should not be considered as opportunities only for people who already have cancer. They may also present prevention and early detection options for people at average and increased risk for developing cancer.

In this era of evidence-based medicine, our progress toward identifying interventions and best practices will come faster and at a lower cost if clinicians and researchers can promote awareness of these studies, and play the essential role of aiding patients to make an informed decision about participation.

Renato Corporation intends to benefit from the steps being taken by the worldwide health care system today by making available, affordable early detection diagnostic service through thousands of private health care providers and wellness clinics today and in the years to come.

This presents enormous opportunity for financial growth for companies engaging and providing such health care. Today, more than ever, government bodies are looking to reduce the economic strain that is put on their country with the ever increasing health care costs.

Advanced Detection Technologies will no doubt be ultimately relied on to help reduce these financial burdens.